[Enhancement of cell growth by human interferons]. 1990

N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
Département de Microbiologie, Université Médicale de la Préfecture de Kyoto, Japan.

The effects of human interferons (HuIFN) on the human osteosarcoma cells were examined. HuIFN-alpha, -beta and -gamma enhanced dose-dependently the cell growth. There was no difference in the degree of the enhancement of the cell growth among HuIFN-alpha, -beta and -gamma. The higher the cell density was, the lower the degree of the enhancement of the cell growth. When HuIFN-gamma was neutralized with anti-HuIFN-gamma, the enhancement of cell growth was not found.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
January 1985, Journal of immunopharmacology,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
January 1980, International archives of allergy and applied immunology,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
February 1988, Journal of interferon research,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
October 1984, European journal of cancer & clinical oncology,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
April 2000, Histology and histopathology,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
January 1982, Comptes rendus des seances de la Societe de biologie et de ses filiales,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
January 1981, In vitro,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
January 1989, Trends in genetics : TIG,
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
February 1983, Journal of immunology (Baltimore, Md. : 1950),
N Yamaguchi, and L J Tong, and Y Yamamura, and G Otsuka, and Y Tamura, and M Kita, and J Imanishi
February 1986, Immunology,
Copied contents to your clipboard!